Concepedia

Publication | Open Access

Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia

DOIFull Paper Access

56

Citations

44

References

2013

Year

Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut, Katharina Henriette Rasp, Barbara Illing, Hartmut Döhner, Konstanze Döhner, Marcus M. Schittenhelm
Molecular Cancer

Abstract

Our data suggest a favorable antileukemic profile for NVP-BGT226 compared to NVP-BEZ235--which provides a strong rationale for clinical evaluation of the dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia.

References

YearCitations

Page 1